BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37085137)

  • 1. Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human Hepatocytes.
    Fan L; Gokaltun A; Maggipinto S; Kitagawa Y; Martyn J; Yeh H; Uygun BE; Yarmush ML; Usta OB
    Cell Mol Gastroenterol Hepatol; 2023; 16(2):243-261. PubMed ID: 37085137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
    Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
    J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria.
    García-Berumen CI; Ortiz-Avila O; Vargas-Vargas MA; Del Rosario-Tamayo BA; Guajardo-López C; Saavedra-Molina A; Rodríguez-Orozco AR; Cortés-Rojo C
    Lipids Health Dis; 2019 Mar; 18(1):78. PubMed ID: 30927921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
    Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
    Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
    Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
    Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria.
    Amorim R; Magalhães CC; Borges F; Oliveira PJ; Teixeira J
    Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low abundance of mitophagy markers is associated with reactive oxygen species overproduction in cows with fatty liver and causes reactive oxygen species overproduction and lipid accumulation in calf hepatocytes.
    Fang Z; Liu G; Zhu M; Wang S; Jiang Q; Loor JJ; Yu H; Hao X; Chen M; Gao W; Lei L; Song Y; Wang Z; Du X; Li X
    J Dairy Sci; 2022 Sep; 105(9):7829-7841. PubMed ID: 35863923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly expressed MT-ND3 positively associated with histological severity of hepatic steatosis.
    Wang HN; Chen HD; Chen KY; Xiao JF; He K; Xiang GA; Xie X
    APMIS; 2014 May; 122(5):443-51. PubMed ID: 24020820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.
    Amorim R; Simões ICM; Veloso C; Carvalho A; Simões RF; Pereira FB; Thiel T; Normann A; Morais C; Jurado AS; Wieckowski MR; Teixeira J; Oliveira PJ
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.
    Bellanti F; Villani R; Tamborra R; Blonda M; Iannelli G; di Bello G; Facciorusso A; Poli G; Iuliano L; Avolio C; Vendemiale G; Serviddio G
    Redox Biol; 2018 May; 15():86-96. PubMed ID: 29220698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis.
    Longhitano L; Distefano A; Amorini AM; Orlando L; Giallongo S; Tibullo D; Lazzarino G; Nicolosi A; Alanazi AM; Saoca C; Macaione V; Aguennouz M; Salomone F; Tropea E; Barbagallo IA; Volti GL; Lazzarino G
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin.
    Grasselli E; Baldini F; Vecchione G; Oliveira PJ; Sardão VA; Voci A; Portincasa P; Vergani L
    Int J Mol Med; 2019 Aug; 44(2):705-712. PubMed ID: 31173180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional perfused human
    Kostrzewski T; Cornforth T; Snow SA; Ouro-Gnao L; Rowe C; Large EM; Hughes DJ
    World J Gastroenterol; 2017 Jan; 23(2):204-215. PubMed ID: 28127194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of metformin against palmitate-induced hepatic cell death.
    Geng Y; Hernández Villanueva A; Oun A; Buist-Homan M; Blokzijl H; Faber KN; Dolga A; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165621. PubMed ID: 31786336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.
    Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P
    J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress.
    Rennert C; Heil T; Schicht G; Stilkerich A; Seidemann L; Kegel-Hübner V; Seehofer D; Damm G
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
    Yu HM; Chung HK; Park KS
    Biochem Biophys Res Commun; 2021 Jun; 558():57-63. PubMed ID: 33895552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.